As a starting point of such, research on the ACE2 gene suggests that female SLE patients have hypomethylation on the ACE2 promoter sites in their CD4(+) T cells (M. Zhao et al., 2014). The gene discussed is ACE2; the disease is systemic lupus erythematosus.